GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaEssentia Corp (TPE:6446) » Definitions » Total Long-Term Liabilities

PharmaEssentia (TPE:6446) Total Long-Term Liabilities : NT$934 Mil (As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is PharmaEssentia Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. PharmaEssentia's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was NT$934 Mil.

PharmaEssentia Total Long-Term Liabilities Historical Data

The historical data trend for PharmaEssentia's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaEssentia Total Long-Term Liabilities Chart

PharmaEssentia Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 524.78 535.84 641.07 1,169.07 1,035.56

PharmaEssentia Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 988.83 1,013.47 1,053.58 1,035.56 933.63

PharmaEssentia Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

PharmaEssentia Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of PharmaEssentia's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaEssentia Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaEssentia Corp (TPE:6446) » Definitions » Total Long-Term Liabilities
Comparable Companies
TPE:6472 TPE:1795 ROCO:4123 TPE:1707 ROCO:4105 TPE:3705 ROCO:4114 TPE:1789 ROCO:6620 TPE:1720 ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 2nd Floor, No. 5, Nangang District, Taipei, TWN, 115
Website
https://www.pharmaessentia.com
PharmaEssentia Corp is engaged in medicine discovery, supplements in developing specialty pharmaceutical reagents, API, and new drug pattern developments. It focuses on Hematology, Oncology, and Infectious Diseases. The company derives its revenue from the sales of medicine products. Geographically, the company generates maximum revenue from America, followed by Europe, Asia (excluding Taiwan), and Taiwan.

PharmaEssentia Headlines

No Headlines